Versant Capital Management’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.5K Sell
997
-1,694
-63% -$28.7K ﹤0.01% 1912
2026
Q1
$42.8K Buy
2,691
+1,234
+85% +$26.8K ﹤0.01% 1333
2025
Q4
$38.3K Hold
1,457
﹤0.01% 1231
2025
Q3
$32.9K Sell
1,457
-663
-31% -$13.7K ﹤0.01% 1277
2025
Q2
$42.1K Buy
2,120
+694
+49% +$13.5K 0.01% 1074
2025
Q1
$24.1K Buy
1,426
+434
+44% +$7.39K ﹤0.01% 1245
2024
Q4
$18.3K Buy
992
+506
+104% +$9.88K ﹤0.01% 1079
2024
Q3
$10.6K Buy
486
+148
+44% +$3.31K ﹤0.01% 1041
2024
Q2
$6.63K Buy
338
+210
+164% +$4.38K ﹤0.01% 1131
2024
Q1
$2.78K Hold
128
﹤0.01% 1247
2023
Q4
$3.7K Buy
128
+81
+172% +$2.17K ﹤0.01% 1080
2023
Q3
$1.26K Sell
47
-317
-87% -$10.8K ﹤0.01% 1465
2023
Q2
$13.5K Sell
364
-85
-19% -$2.96K ﹤0.01% 656
2023
Q1
$14K Buy
+449
New +$14.4K ﹤0.01% 617

Other funds holding FLGT